<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><meta name="description" content="The optimal_multiarm_normal function enables planning of
multi-arm phase II/III drug development programs with optimal sample size
allocation and go/no-go decision rules. For normally distributed endpoints,
the treatment effect is measured by the standardized difference in means
(Delta). So far, only three-arm trials with two treatments and one control
are supported. The assumed true treatment effects can be assumed fixed or
modelled by a prior distribution. The R Shiny application
prior visualizes the
prior distributions used in this package. Fast computing is enabled by
parallel programming."><title>Optimal phase II/III drug development planning for multi-arm programs with
normally distributed endpoint — optimal_multiarm_normal • drugdevelopR</title><script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><link href="../deps/bootstrap-5.2.2/bootstrap.min.css" rel="stylesheet"><script src="../deps/bootstrap-5.2.2/bootstrap.bundle.min.js"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous"><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous"><!-- bootstrap-toc --><script src="https://cdn.jsdelivr.net/gh/afeld/bootstrap-toc@v1.0.1/dist/bootstrap-toc.min.js" integrity="sha256-4veVQbu7//Lk5TSmc7YV48MxtMy98e26cf5MrgZYnwo=" crossorigin="anonymous"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><!-- search --><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="Optimal phase II/III drug development planning for multi-arm programs with
normally distributed endpoint — optimal_multiarm_normal"><meta property="og:description" content="The optimal_multiarm_normal function enables planning of
multi-arm phase II/III drug development programs with optimal sample size
allocation and go/no-go decision rules. For normally distributed endpoints,
the treatment effect is measured by the standardized difference in means
(Delta). So far, only three-arm trials with two treatments and one control
are supported. The assumed true treatment effects can be assumed fixed or
modelled by a prior distribution. The R Shiny application
prior visualizes the
prior distributions used in this package. Fast computing is enabled by
parallel programming."><!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]--></head><body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>
    

    <nav class="navbar fixed-top navbar-light navbar-expand-lg bg-light"><div class="container">
    
    <a class="navbar-brand me-2" href="../index.html">drugdevelopR</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">0.1.0</small>

    
    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto"><li class="active nav-item">
  <a class="nav-link" href="../reference/index.html">Reference</a>
</li>
<li class="nav-item dropdown">
  <a href="#" class="nav-link dropdown-toggle" data-bs-toggle="dropdown" role="button" aria-expanded="false" aria-haspopup="true" id="dropdown-articles">Articles</a>
  <div class="dropdown-menu" aria-labelledby="dropdown-articles">
    <a class="dropdown-item" href="../articles/Bias_adjustment.html">Methods for Discounting of Phase II Results - Bias Adjustment</a>
    <a class="dropdown-item" href="../articles/Binary_distributed_outcomes.html">Binary Distributed Outcome Variables</a>
    <a class="dropdown-item" href="../articles/Fixed_and_prior_distributions.html">Fixed effects and prior distributions</a>
    <a class="dropdown-item" href="../articles/Interpreting_Output.html">Interpreting the Rest of the Output</a>
    <a class="dropdown-item" href="../articles/More_Parameters.html">More Parameters to Adapt to Specific Settings and Individual Needs</a>
    <a class="dropdown-item" href="../articles/Multiarm_Trials.html">Multiarm - Methods for Multi-Arm Programs</a>
    <a class="dropdown-item" href="../articles/Multiple_Endpoints.html">Programs for Trials with Multiple Endpoints</a>
    <a class="dropdown-item" href="../articles/Multitrial.html">Multitrial Programs - Methods for Programs with Several Phase III Trials</a>
    <a class="dropdown-item" href="../articles/Time-to-event_outcomes.html">Time-to-event Outcome Variables</a>
    <a class="dropdown-item" href="../articles/introduction-to-drugdevelopR.html">Introduction to planning phase II and phase III trials with drugdevelopR</a>
  </div>
</li>
<li class="nav-item">
  <a class="nav-link" href="../news/index.html">Changelog</a>
</li>
      </ul><form class="form-inline my-2 my-lg-0" role="search">
        <input type="search" class="form-control me-sm-2" aria-label="Toggle navigation" name="search-input" data-search-index="../search.json" id="search-input" placeholder="Search for" autocomplete="off"></form>

      <ul class="navbar-nav"><li class="nav-item">
  <a class="external-link nav-link" href="https://github.com/Sterniii3/drugdevelopR/" aria-label="github">
    <span class="fab fa fab fa-github fa-lg"></span>
     
  </a>
</li>
      </ul></div>

    
  </div>
</nav><div class="container template-reference-topic">
<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">
      <img src="" class="logo" alt=""><h1>Optimal phase II/III drug development planning for multi-arm programs with
normally distributed endpoint</h1>
      <small class="dont-index">Source: <a href="https://github.com/Sterniii3/drugdevelopR/blob/HEAD/R/optimal_multiarm_normal.R" class="external-link"><code>R/optimal_multiarm_normal.R</code></a></small>
      <div class="d-none name"><code>optimal_multiarm_normal.Rd</code></div>
    </div>

    <div class="ref-description section level2">
    <p>The <code>optimal_multiarm_normal</code> function enables planning of
multi-arm phase II/III drug development programs with optimal sample size
allocation and go/no-go decision rules. For normally distributed endpoints,
the treatment effect is measured by the standardized difference in means
(Delta). So far, only three-arm trials with two treatments and one control
are supported. The assumed true treatment effects can be assumed fixed or
modelled by a prior distribution. The R Shiny application
<a href="https://web.imbi.uni-heidelberg.de/prior/" class="external-link">prior</a> visualizes the
prior distributions used in this package. Fast computing is enabled by
parallel programming.</p>
    </div>

    <div class="section level2">
    <h2 id="ref-usage">Usage<a class="anchor" aria-label="anchor" href="#ref-usage"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span><span class="fu">optimal_multiarm_normal</span><span class="op">(</span></span>
<span>  <span class="va">Delta1</span>,</span>
<span>  <span class="va">Delta2</span>,</span>
<span>  <span class="va">n2min</span>,</span>
<span>  <span class="va">n2max</span>,</span>
<span>  <span class="va">stepn2</span>,</span>
<span>  <span class="va">kappamin</span>,</span>
<span>  <span class="va">kappamax</span>,</span>
<span>  <span class="va">stepkappa</span>,</span>
<span>  <span class="va">alpha</span>,</span>
<span>  <span class="va">beta</span>,</span>
<span>  <span class="va">c2</span>,</span>
<span>  <span class="va">c3</span>,</span>
<span>  <span class="va">c02</span>,</span>
<span>  <span class="va">c03</span>,</span>
<span>  K <span class="op">=</span> <span class="cn">Inf</span>,</span>
<span>  N <span class="op">=</span> <span class="cn">Inf</span>,</span>
<span>  S <span class="op">=</span> <span class="op">-</span><span class="cn">Inf</span>,</span>
<span>  steps1 <span class="op">=</span> <span class="fl">0</span>,</span>
<span>  stepm1 <span class="op">=</span> <span class="fl">0.5</span>,</span>
<span>  stepl1 <span class="op">=</span> <span class="fl">0.8</span>,</span>
<span>  <span class="va">b1</span>,</span>
<span>  <span class="va">b2</span>,</span>
<span>  <span class="va">b3</span>,</span>
<span>  <span class="va">strategy</span>,</span>
<span>  num_cl <span class="op">=</span> <span class="fl">1</span></span>
<span><span class="op">)</span></span></code></pre></div>
    </div>

    <div class="section level2">
    <h2 id="arguments">Arguments<a class="anchor" aria-label="anchor" href="#arguments"></a></h2>
    <dl><dt>Delta1</dt>
<dd><p>assumed true treatment effect as the standardized difference in
means for treatment arm 1</p></dd>


<dt>Delta2</dt>
<dd><p>assumed true treatment effect as the standardized difference in
means for treatment arm 2</p></dd>


<dt>n2min</dt>
<dd><p>minimal total sample size in phase II, must be divisible by 3</p></dd>


<dt>n2max</dt>
<dd><p>maximal total sample size in phase II, must be divisible by 3</p></dd>


<dt>stepn2</dt>
<dd><p>stepsize for the optimization over n2, must be divisible by 3</p></dd>


<dt>kappamin</dt>
<dd><p>minimal threshold value kappa for the go/no-go decision rule</p></dd>


<dt>kappamax</dt>
<dd><p>maximal threshold value  kappa for the go/no-go decision rule</p></dd>


<dt>stepkappa</dt>
<dd><p>step size for the optimization over the threshold value kappa</p></dd>


<dt>alpha</dt>
<dd><p>one-sided significance level/family-wise error rate</p></dd>


<dt>beta</dt>
<dd><p>type-II error rate for any pair, i.e. <code>1 - beta</code> is the (any-pair) power for calculation of the sample size for phase III</p></dd>


<dt>c2</dt>
<dd><p>variable per-patient cost for phase II</p></dd>


<dt>c3</dt>
<dd><p>variable per-patient cost for phase III</p></dd>


<dt>c02</dt>
<dd><p>fixed cost for phase II</p></dd>


<dt>c03</dt>
<dd><p>fixed cost for phase III</p></dd>


<dt>K</dt>
<dd><p>constraint on the costs of the program, default: <code>Inf</code>, e.g. no constraint</p></dd>


<dt>N</dt>
<dd><p>constraint on the total expected sample size of the program, default: <code>Inf</code>, e.g. no constraint</p></dd>


<dt>S</dt>
<dd><p>constraint on the expected probability of a successful program, default: <code>-Inf</code>, e.g. no constraint</p></dd>


<dt>steps1</dt>
<dd><p>lower boundary for effect size category "small", default: 0</p></dd>


<dt>stepm1</dt>
<dd><p>lower boundary for effect size category "medium" = upper boundary for effect size category "small" default: 0.5</p></dd>


<dt>stepl1</dt>
<dd><p>lower boundary for effect size category "large" = upper boundary for effect size category "medium", default: 0.8</p></dd>


<dt>b1</dt>
<dd><p>expected gain for effect size category "small"</p></dd>


<dt>b2</dt>
<dd><p>expected gain for effect size category "medium"</p></dd>


<dt>b3</dt>
<dd><p>expected gain for effect size category "large"</p></dd>


<dt>strategy</dt>
<dd><p>choose strategy: 1 (only the best promising candidate), 2 (all promising candidates) or 3 (both strategies)</p></dd>


<dt>num_cl</dt>
<dd><p>number of clusters used for parallel computing, default: 1</p></dd>

</dl></div>
    <div class="section level2">
    <h2 id="value">Value<a class="anchor" aria-label="anchor" href="#value"></a></h2>
    

<p>The output of the function is a <code>data.frame</code> object containing the optimization results:</p><dl><dt>u</dt>
<dd><p>maximal expected utility under the optimization constraints, i.e. the expected utility of the optimal sample size and threshold value</p></dd>
<dt>Kappa</dt>
<dd><p>optimal threshold value for the decision rule to go to phase III</p></dd>
<dt>n2</dt>
<dd><p>total sample size for phase II; rounded to the next even natural number</p></dd>

<dt>n3</dt>
<dd><p>total sample size for phase III; rounded to the next even natural number</p></dd>

<dt>n</dt>
<dd><p>total sample size in the program; n = n2 + n3</p></dd>

<dt>K</dt>
<dd><p>maximal costs of the program</p></dd>

<dt>pgo</dt>
<dd><p>probability to go to phase III</p></dd>

<dt>sProg</dt>
<dd><p>probability of a successful program</p></dd>

<dt>sProg1</dt>
<dd><p>probability of a successful program with "small" treatment effect in phase III</p></dd>

<dt>sProg2</dt>
<dd><p>probability of a successful program with "medium" treatment effect in phase III</p></dd>

<dt>sProg3</dt>
<dd><p>probability of a successful program with "large" treatment effect in phase III</p></dd>

<dt>K2</dt>
<dd><p>expected costs for phase II</p></dd>

<dt>K3</dt>
<dd><p>expected costs for phase III</p></dd>

</dl><p>and further input parameters. Taking <code>cat(comment())</code> of the
data frame lists the used optimization sequences, start and
finish date of the optimization procedure.</p>
    </div>
    <div class="section level2">
    <h2 id="references">References<a class="anchor" aria-label="anchor" href="#references"></a></h2>
    <p>Cohen, J. (1988). Statistical power analysis for the behavioral sciences.</p>
    </div>
    <div class="section level2">
    <h2 id="last-edited-by">Last Edited By<a class="anchor" aria-label="anchor" href="#last-edited-by"></a></h2>
    <p>Johannes Cepicka</p>
    </div>
    <div class="section level2">
    <h2 id="last-edit-date">Last Edit Date<a class="anchor" aria-label="anchor" href="#last-edit-date"></a></h2>
    <p>2022-04-23</p>
    </div>

    <div class="section level2">
    <h2 id="ref-examples">Examples<a class="anchor" aria-label="anchor" href="#ref-examples"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span class="r-in"><span><span class="va">res</span> <span class="op">&lt;-</span> <span class="fu">optimal_multiarm_normal</span><span class="op">(</span>Delta1 <span class="op">=</span> <span class="fl">0.375</span>, Delta2 <span class="op">=</span> <span class="fl">0.625</span>,     </span></span>
<span class="r-in"><span>  n2min <span class="op">=</span> <span class="fl">20</span>, n2max <span class="op">=</span> <span class="fl">100</span>, stepn2 <span class="op">=</span> <span class="fl">4</span>,                   <span class="co"># define optimization set for n2</span></span></span>
<span class="r-in"><span>  kappamin <span class="op">=</span> <span class="fl">0.02</span>, kappamax <span class="op">=</span> <span class="fl">0.2</span>, stepkappa <span class="op">=</span> <span class="fl">0.02</span>,     <span class="co"># define optimization set for kappa</span></span></span>
<span class="r-in"><span>  alpha <span class="op">=</span> <span class="fl">0.05</span>, beta <span class="op">=</span> <span class="fl">0.1</span>,                              <span class="co"># drug development planning parameters</span></span></span>
<span class="r-in"><span>  c2 <span class="op">=</span> <span class="fl">0.675</span>, c3 <span class="op">=</span> <span class="fl">0.72</span>, c02 <span class="op">=</span> <span class="fl">15</span>, c03 <span class="op">=</span> <span class="fl">20</span>,             <span class="co"># define fixed and variable costs for phase II and III</span></span></span>
<span class="r-in"><span>  K <span class="op">=</span> <span class="cn">Inf</span>, N <span class="op">=</span> <span class="cn">Inf</span>, S <span class="op">=</span> <span class="op">-</span><span class="cn">Inf</span>,                            <span class="co"># set maximal costs/ expected sample size for the program or minimal expected probability of a successful program</span></span></span>
<span class="r-in"><span>  steps1 <span class="op">=</span> <span class="fl">0</span>,                                            <span class="co"># define lower boundary for "small"</span></span></span>
<span class="r-in"><span>  stepm1 <span class="op">=</span> <span class="fl">0.5</span>,                                          <span class="co"># "medium"</span></span></span>
<span class="r-in"><span>  stepl1 <span class="op">=</span> <span class="fl">0.8</span>,                                          <span class="co"># and "large" treatment effect size categories as proposed by e.g. Cohen (1988)</span></span></span>
<span class="r-in"><span>  b1 <span class="op">=</span> <span class="fl">3000</span>, b2 <span class="op">=</span> <span class="fl">8000</span>, b3 <span class="op">=</span> <span class="fl">10000</span>,                      <span class="co"># define expected benefit for a "small", "medium" and "large" treatment effect</span></span></span>
<span class="r-in"><span>  strategy <span class="op">=</span> <span class="fl">1</span>,</span></span>
<span class="r-in"><span>  num_cl <span class="op">=</span> <span class="fl">1</span><span class="op">)</span>                                            <span class="co"># set number of cores used for parallelized computing (check maximum number possible with detectCores())</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Optimization progress:</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>   |                                                                              |                                                                      |   0%  |                                                                              |=======                                                               |  10%  |                                                                              |==============                                                        |  20%  |                                                                              |=====================                                                 |  30%  |                                                                              |============================                                          |  40%  |                                                                              |===================================                                   |  50%  |                                                                              |==========================================                            |  60%  |                                                                              |=================================================                     |  70%  |                                                                              |========================================================              |  80%  |                                                                              |===============================================================       |  90%  |                                                                              |======================================================================| 100%</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Optimization result:</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>   Strategy       u kappa  n2  n3   n  pgo sProg Delta1 Delta2   K   N    S K2</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 1        1 2924.13  0.06 100 164 264 0.99   0.8  0.375  0.625 Inf Inf -Inf 82</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    K3 sProg2 sProg3 steps1 stepm1 stepl1 alpha beta c02 c03    c2   c3   b1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 1 138    0.8      0      0    0.5    0.8  0.05  0.1  15  20 0.675 0.72 3000</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>     b2    b3</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 1 8000 10000</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-in"><span><span class="va">res</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span>   Strategy       u kappa  n2  n3   n  pgo sProg Delta1 Delta2   K   N    S K2</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 1        1 2924.13  0.06 100 164 264 0.99   0.8  0.375  0.625 Inf Inf -Inf 82</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    K3 sProg2 sProg3 steps1 stepm1 stepl1 alpha beta c02 c03    c2   c3   b1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 1 138    0.8      0      0    0.5    0.8  0.05  0.1  15  20 0.675 0.72 3000</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>     b2    b3</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 1 8000 10000</span>
<span class="r-in"><span><span class="fu"><a href="https://rdrr.io/r/base/cat.html" class="external-link">cat</a></span><span class="op">(</span><span class="fu"><a href="https://rdrr.io/r/base/comment.html" class="external-link">comment</a></span><span class="op">(</span><span class="va">res</span><span class="op">)</span><span class="op">)</span>                                        <span class="co"># displays the optimization sequence, start and finish date of the optimization procedure.</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> optimization sequence Kappa: 0.02 0.04 0.06 0.08 0.1 0.12 0.14 0.16 0.18 0.2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> optimization sequence n2: 20 24 28 32 36 40 44 48 52 56 60 64 68 72 76 80 84 88 92 96 100 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> set on date: 2023-03-04 19:13:07 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> finish date: 2023-03-04 19:14:53</span>
<span class="r-in"><span></span></span>
</code></pre></div>
    </div>
  </main><aside class="col-md-3"><nav id="toc"><h2>On this page</h2>
    </nav></aside></div>


    <footer><div class="pkgdown-footer-left">
  <p></p><p>Developed by Stella Preussler.</p>
</div>

<div class="pkgdown-footer-right">
  <p></p><p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.0.7.</p>
</div>

    </footer></div>

  

  

  </body></html>

